OTOFARMA: BOARD OF DIRECTORS APPROVES HALF-YEAR REPORT AND PRO FORMA CONSOLIDATED FINANCIAL STATEMENTS AS AT 30 JUNE 2025

Protocollo

172828

Comunicato

Azienda

OTOFARMA

Tipo

Comunicato

SDIR

SDIRNIS

Lingua

ENG

Data creazione

Wed, 10/01/2025 - 11:18

Data ricezione SDIR

Wed, 10/01/2025 - 11:18

Data embargo SDIR

Wed, 10/01/2025 - 11:18

Data diffusione SDIR

Wed, 10/01/2025 - 11:18

Mercato

Euronext Growth Milan